(NASDAQ: BGMS) Bio Green Med Solution's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 76.08%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 105.17%.
Bio Green Med Solution's earnings in 2025 is -$6,974,000.On average, 3 Wall Street analysts forecast BGMS's earnings for 2025 to be -$5,897,811, with the lowest BGMS earnings forecast at -$5,666,524, and the highest BGMS earnings forecast at -$6,071,276. On average, 3 Wall Street analysts forecast BGMS's earnings for 2026 to be -$5,597,922, with the lowest BGMS earnings forecast at -$5,378,396, and the highest BGMS earnings forecast at -$5,762,567.
In 2027, BGMS is forecast to generate $18,343,192 in earnings, with the lowest earnings forecast at $17,623,851 and the highest earnings forecast at $18,882,697.